Загрузка...
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
BACKGROUND: This systematic review addresses the question “What is the optimal targeted therapy for female patients with early-stage human epidermal growth factor receptor 2 (her2)–positive breast cancer?” METHODS: The medline and embase databases were searched for the period January 2008 to May 201...
Сохранить в:
| Опубликовано в: : | Curr Oncol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Multimed Inc.
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381787/ https://ncbi.nlm.nih.gov/pubmed/25848335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2322 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|